Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
Clinical trial NCT00195663 · COMPLETED
Trial details
- NCT number
- NCT00195663
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-12-01
- Primary completion
- 2004-04-01
- Enrollment
- 799
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.